US Broker Ratings

Harrow, Inc. (HROW): Analyst Ratings Suggest 81% Upside Potential in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW) stands out as a compelling opportunity within the healthcare sector, specifically in the niche of ophthalmic pharmaceuticals. With its roots dating back..

MannKind Corporation (MNKD): Analyst Consensus Suggests a Compelling 166.34% Upside Potential

MannKind Corporation (MNKD), a biopharmaceutical company specializing in treatments for endocrine and orphan lung diseases, is generating considerable attention in the healthcare investment sector. With a..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Steady Revenue Growth with Modest Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, provides essential management and operational services to medical care facilities across the United..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Sector with Strategic Partnerships

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is making waves with its innovative approach to drug development, particularly in the fields of..

AdaptHealth Corp. (AHCO) Stock Analysis: A 39% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 39.19%..

Evotec SE (EVO) Stock Analysis: Navigating a 46% Upside Potential in the Biotech Arena

For investors with an eye on the dynamic healthcare sector, Evotec SE (EVO) presents an intriguing prospect. As a prominent player in the drug discovery and..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A 167.92% Upside Potential in Biotech

For investors navigating the dynamic landscape of the biotechnology sector, Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents an intriguing opportunity, with analyst ratings suggesting a potential upside..

Establishment Labs Holdings Inc (ESTA): Investor Outlook on a High-Potential Medical Device Innovator

Establishment Labs Holdings Inc (NASDAQ: ESTA) stands out as a significant player in the healthcare sector, particularly within the medical devices industry. Headquartered in Alajuela, Costa..

The Pennant Group, Inc. (PNTG) Stock Analysis: A 30% Potential Upside in Healthcare Services

For investors seeking opportunities in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case with its promising growth prospects and strong analyst..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unlocking 97.87% Potential Upside with Cutting-Edge Therapeutics

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a key player in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. Headquartered in Durham,..

Schrödinger, Inc. (SDGR): Exploring a 54% Upside Amidst Rapid Revenue Growth

Schrödinger, Inc. (NASDAQ: SDGR) is carving out a significant niche within the healthcare sector, specifically in the health information services industry. With a market capitalization of..

Arrowhead Pharmaceuticals, Inc. (ARWR) Investor Outlook: Unpacking a Potential 161% Upside

Arrowhead Pharmaceuticals, Inc. (ARWR), a key player in the biotechnology sector, has captured investor attention with its promise of significant upside potential. Based in Pasadena, California,..

Evolent Health, Inc. (EVH) Stock Analysis: What a 29.53% Potential Upside Means for Investors

Evolent Health, Inc. (NYSE: EVH), a prominent player in the Health Information Services industry, is capturing investor attention with a compelling potential upside of 29.53%, according..

Teladoc Health, Inc. (TDOC) Investor Outlook: Unpacking a 11.20% Potential Upside Amid Healthcare’s Digital Revolution

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in virtual healthcare services, has captured the attention of investors with its potential for a 11.20% upside, despite the..

Surgery Partners, Inc. (SGRY) Investor Outlook: Evaluating a 42% Upside Potential in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) has been steadily carving out a significant niche in the healthcare sector, specifically within the medical care facilities industry. With a..

NovoCure Limited (NVCR) Investor Outlook: Analyzing a Potential 92.84% Upside in the Healthcare Sector

NovoCure Limited (NASDAQ: NVCR) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Baar, Switzerland, NovoCure is at the..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 39.71% Potential Upside Amid Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is making waves in the healthcare sector, specifically within the drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With..

89bio, Inc. (ETNB) Stock Analysis: A Biotech Play with 188% Upside Potential

89bio, Inc. (NASDAQ: ETNB) is emerging as a compelling opportunity in the biotechnology sector, captivating investors’ attention with its promising upside potential of 188.20%. As a..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Examining a 67.60% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) presents an intriguing opportunity for investors within the healthcare sector, particularly those focused on the burgeoning field of medical devices. With..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating the Upside Potential in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, focuses on advancing life science technologies through its innovative platforms. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds